Abstract

How has the current crisis caused by the COVID-19 pandemic affected R&D and innovation in Poland? Numerous international studies conducted after the Great Depression in 2008–2010 show a strong procyclicality of investments in R&D and innovation in companies: investments rise during the economic upturn and fall sharply during the crisis. This procyclicality is driven within firms both by internal financial resources and by differences in market incentives to innovate. It seems likely that the COVID-19 crisis caused financial weakness for many actors, having the most significant impact on the willingness or ability of smaller firms to support R&D and innovation. However, where firms are able to sustain these investments, evidence from the crisis a decade ago suggests that they will be more likely to survive, grow more strongly, and have higher profitability. Based on the analysis of the literature and macroeconomic data, this paper presents several recommendations that, if implemented by R&D actors, could help increase the efficiency of operations, even in times of crisis.